GET DAILY SIGNALSChime Financial (CHYM) Reports Strong Q3 2026 Results with +32% Revenue Growth
Key Takeaways
- Chime Financial reported third-quarter 2026 revenue of $718.0 million, up 32% year over year and above consensus estimates of roughly $700 million.
- GAAP diluted earnings per share came in at $0.11, beating the $0.09 consensus and delivering a third consecutive quarter of GAAP profitability.
- Net income reached $43.7 million versus a $54.7 million loss a year earlier, while adjusted EBITDA rose to $137 million, a 19% margin.
- Active members grew 20% to 10.9 million, and average revenue per active member (ARPAM) rose 10% to $270.
- Management raised its full-year 2026 revenue growth outlook to 28% and guided fourth-quarter revenue to $757–$767 million, above analyst expectations.
Why These Results Matter
Chime Financial's third-quarter results mark an important checkpoint as the fintech moves from high-growth startup mode toward sustainable profitability as a public company. Following its IPO in June 2025, attention has focused on whether the company can expand its member base while turning that growth into consistent earnings. Three straight quarters of GAAP profitability now stand out as a clear milestone for a business that posted deep losses in 2025. The quarter also arrives alongside a major strategic move: the planned $590 million acquisition of Stride Bank, which would give Chime direct control of a national banking license. Together, the numbers provide fresh insight into both near-term execution and longer-term strategy.
Breaking Down the Reported Numbers
For the third quarter ended September 30, 2026, CHYM posted revenue of $718.0 million, a 32% increase from $543.5 million a year earlier and ahead of the roughly $700.5 million consensus. GAAP diluted EPS reached $0.11, topping the $0.09 estimate and reversing from a $0.15 per-share loss in the prior-year period. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Both core revenue engines contributed. Payments revenue climbed 22% to $444 million, or 26% when including Outbound Instant Transfer revenue. Platform-related revenue jumped 52% to $274 million, driven by continued scaling of MyPay and Instant Loans. Gross profit came in at $646.1 million for a 90% margin.
Net income totaled $43.7 million, or a 6% net margin, compared with a $54.7 million loss last year. Adjusted EBITDA reached $137 million, reflecting a 19% margin and a 14-percentage-point improvement year over year. Active members rose 20% to 10.9 million, while ARPAM increased 10% to $270.
Market Reaction and Sentiment
Investors reacted positively. CHYM shares closed up 5.78% on November 4 and extended gains in after-hours trading. The move reflects growing confidence that revenue growth is now paired with meaningful operating leverage, as the adjusted EBITDA margin expanded sharply. The raised guidance for the fourth quarter and full year also signaled management’s confidence in demand heading into 2027. That said, some analysts note that positive surprises are moderating, suggesting the valuation already prices in much of the improving fundamentals.
Forward Outlook and Factors to Watch
Management now expects full-year 2026 revenue growth of 28%, up from its previous target, and projects fourth-quarter revenue of $757–$767 million, above consensus. The pending $590 million acquisition of Stride Bank remains the largest longer-term catalyst, with closing targeted for the first half of 2027 pending regulatory approval. Direct ownership of a bank license could lower partner-bank fees and speed product development, though it brings added regulatory oversight, including the $10 billion Durbin threshold for debit interchange fees.
Other items worth monitoring include scaling of MyPay and Instant Loans, early traction of the Chime Prime premium tier, integration of recently announced credit products, and continued cost discipline after the 10% workforce reduction announced earlier in 2026. These factors will determine whether CHYM can maintain both growth and profitability as it transitions into a more integrated financial institution.
Exploring Automated Trading Ideas
In my own workflow, I often turn to Tickeron’s AI Trading Bots when looking at names like this. The platform lets me review automated strategies and pattern-based signals that complement traditional fundamental analysis, helping surface potential entry or exit ideas based on current technical setups.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
CHYM in -5.34% downward trend, declining for three consecutive days on October 26, 2026
Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where CHYM declined for three days, in 63 of 75 cases, the price declined further within the following month. The odds of a continued downward trend are 84%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 23, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CHYM as a result. In 18 of 22 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 82%.
The Moving Average Convergence Divergence Histogram (MACD) for CHYM turned negative on October 27, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 9 similar instances when the indicator turned negative. In 7 of the 9 cases the stock turned lower in the days that followed. This puts the odds of success at 78%.
CHYM broke above its upper Bollinger Band on October 09, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Bullish Trend Analysis
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where CHYM's RSI Oscillator exited the oversold zone, 9 of 14 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 64%.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 5 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +1.12% 3-day Advance, the price is estimated to grow further. Considering data from situations where CHYM advanced for three days, in 55 of 69 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.
The Aroon Indicator entered an Uptrend today. In 45 of 61 cases where CHYM Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 74%.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 17 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 38 (best 1 - 100 worst), indicating steady price growth. CHYM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 57 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (8.050) is normal, around the industry mean (-1.902). P/E Ratio (5.552) is within average values for comparable stocks, (15.583). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.824). Dividend Yield (0.000) settles around the average of (0.072) among similar stocks. P/S Ratio (4.916) is also within normal values, averaging (70.854).
The Tickeron SMR rating for this company is 91 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CHYM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
Industry PackagedSoftware
Advertisement